35 results on '"Reydel, Antje"'
Search Results
2. Outcomes of patients with active cancer undergoing transcatheter aortic valve replacement
3. P2Y12 inhibition by clopidogrel increases adverse clinical events after transcatheter aortic valve replacement
4. COVID-19 promotes endothelial dysfunction and thrombogenicity: role of proinflammatory cytokines/SGLT2 prooxidant pathway
5. Determinants and treatments of heart failure after transcatheter aortic valve implantation: moving up a notch.
6. Impact of Primary Hemostasis Disorders on Late Major Bleeding Events among Anticoagulated Atrial Fibrillation Patients Treated by TAVR
7. Baseline mean platelet volume is a strong predictor of major and life-threatening bleedings after transcatheter aortic valve replacement
8. Combination of Primary Hemostatic Disorders and Atrial Fibrillation Increases Bleeding Events Following Transcatheter Aortic Valve Replacement
9. Discrepancy in Von Willebrand Abnormalities Between Degenerative and Functional Mitral Regurgitation
10. Incomplete Recovery From Takotsubo Syndrome Is a Major Determinant of Cardiovascular Mortality
11. Acute kidney injury and acute kidney recovery following Transcatheter Aortic Valve Replacement
12. Electrocardiographic Strain Pattern Is a Major Determinant of Rehospitalization for Heart Failure After Transcatheter Aortic Valve Replacement
13. Risk and Severity of COVID-19 and ABO Blood Group in Transcatheter Aortic Valve Patients
14. Increased susceptibility to SARS‐CoV‐2 infection in patients with reduced left ventricular ejection fraction
15. Impact of residual inflammation on myocardial recovery and cardiovascular outcome in Takotsubo patients
16. Predictive Impact of Paravalvular Leak Assessments on Clinical Outcomes Following Transcatheter Aortic Valve Replacement
17. Periprocedural Predictors of New-Onset Conduction Abnormalities After Transcatheter Aortic Valve Replacement
18. Paradoxical Increase of Stroke in Patients with Defect of High Molecular Weight Multimers of the von Willebrand Factors following Transcatheter Aortic Valve Replacement
19. Systemic Inflammatory Response Syndrome Is a Major Determinant of Cardiovascular Outcome in Takotsubo Syndrome
20. P2Y12 Inhibition by Clopidogrel Increases Periprocedural Bleeds in Patients Undergoing Transcatheter Aortic Valve Replacement
21. Does Transcatheter Aortic Valve Replacement Modulate the Kinetic of Superoxide Anion Generation?
22. Impact of Antithrombotic Regimen and Platelet Inhibition Extent on Leaflet Thrombosis Detected by Cardiac MDCT after Transcatheter Aortic Valve Replacement
23. Increased susceptibility to SARS‐CoV‐2 infection in patients with reduced left ventricular ejection fraction.
24. Impact of residual inflammation on myocardial recovery and cardiovascular outcome in Takotsubo patients.
25. Primary Hemostatic Disorders and Late Major Bleeding After Transcatheter Aortic Valve Replacement
26. CT-ADP Point-of-Care Assay Predicts 30-Day Paravalvular Aortic Regurgitation and Bleeding Events following Transcatheter Aortic Valve Replacement
27. The extent of P2Y12 inhibition by clopidogrel in diabetes mellitus patients with acute coronary syndrome is not related to glycaemic control: Roles of white blood cell count and body weight
28. Impact of Primary Hemostasis Disorders on Late Major Bleeding Events among Anticoagulated Atrial Fibrillation Patients Treated by TAVR.
29. The extent of P2Y12 inhibition by clopidogrel in diabetes mellitus patients with acute coronary syndrome is not related to glycaemic control: Roles of white blood cell count and body weight
30. Abstract 12030: P2Y12Inhibition by Clopidogrel Increases Periprocedural Bleeds in Patients Undergoing Transcatheter Aortic Valve Replacement
31. Abstract 12187: Paradoxical Increase of Stroke in Patients With Primary Hemostasis Disorders Following Transcatheter Aortic Valve Replacement
32. Abstract 14094: Periprocedural Predictors of New-Onset Conduction Abnormalities After Transcatheter Aortic Valve Replacement
33. P2Y12 Inhibition by Clopidogrel Increases Periprocedural Bleeds in Patients Undergoing Transcatheter Aortic Valve Replacement.
34. P2Y 12 Inhibition by Clopidogrel Increases Periprocedural Bleeds in Patients Undergoing Transcatheter Aortic Valve Replacement.
35. Unexpected Problems of Antithrombotic Therapy with An Unusual Side Effect of Vitamin K Antagonists after Mitral Valve Replacement.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.